Ortin Global Ltd

AI

Ortin Global Ltd

₹ 12.4 -0.40%
20 Nov - close price
About

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Key Points

Business Overview:[1]
OLL is engaged in the manufacturing and trading of pharmaceuticals, drugs, and Intermediates and is also engaged in real estate.

  • Market Cap ₹ 10.1 Cr.
  • Current Price ₹ 12.4
  • High / Low ₹ 21.3 / 11.3
  • Stock P/E
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0

Pros

Cons

  • Promoter holding is low: 1.24%
  • Promoter holding has decreased over last 3 years: -6.13%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2011 Mar 2012 Jun 2012
19.81 19.77 15.93
17.13 20.77 13.85
Operating Profit 2.68 -1.00 2.08
OPM % 13.53% -5.06% 13.06%
0.01 0.19 0.03
Interest 0.55 0.98 1.12
Depreciation 0.34 0.39 0.33
Profit before tax 1.80 -2.18 0.66
Tax % 33.33% -11.93% 33.33%
1.20 -1.92 0.44
EPS in Rs 3.24 -1.14 0.26
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
60.29 62.72 61.57 79.63 167.51 197.36 8.16 8.23 6.00 2.01 0.34 0.10
53.80 56.83 56.12 74.22 160.83 191.66 6.92 7.85 5.47 6.40 1.23 1.13
Operating Profit 6.49 5.89 5.45 5.41 6.68 5.70 1.24 0.38 0.53 -4.39 -0.89 -1.03
OPM % 10.76% 9.39% 8.85% 6.79% 3.99% 2.89% 15.20% 4.62% 8.83% -218.41% -261.76% -1,030.00%
-0.00 0.57 0.32 0.45 0.13 0.18 0.05 0.19 0.01 -1.98 0.06 0.31
Interest 3.52 3.42 2.94 3.49 3.22 3.21 0.87 0.81 0.40 0.48 -0.00 -0.00
Depreciation 1.64 1.65 1.70 1.69 1.75 1.96 0.29 0.29 0.25 0.23 0.01 -0.00
Profit before tax 1.33 1.39 1.13 0.68 1.84 0.71 0.13 -0.53 -0.11 -7.08 -0.84 -0.72
Tax % 32.33% 41.01% 55.75% -0.00% 30.43% 181.69% -623.08% -24.53% -18.18% 13.56% 1.19% 2.78%
0.90 0.83 0.50 0.68 1.28 -0.56 0.95 -0.40 -0.09 -8.04 -0.85 -0.74
EPS in Rs 0.53 0.49 0.30 0.40 0.76 -0.33 1.17 -0.49 -0.11 -9.89 -1.05 -0.91
Dividend Payout % -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% -0.00%

(S): Standalone figures, shown where consolidated figures are not available.

Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: -5%
5 Years: -15%
3 Years: -14%
1 Year: 2%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S) Sep 2026 (S)
Equity Capital 16.94 16.94 16.94 16.94 16.94 16.94 8.13 8.13 8.13 8.13 8.13 8.13 8.13
Reserves 5.50 6.33 6.46 7.14 8.15 6.88 3.22 2.83 2.73 -5.31 -6.15 -6.89 -7.50
20.96 20.85 17.34 17.34 19.47 19.57 6.94 6.14 6.45 1.80 0.25 1.01 1.23
23.87 21.22 20.79 32.24 60.53 73.13 2.97 3.61 3.89 2.05 1.55 2.40 2.65
Total Liabilities 67.27 65.34 61.53 73.66 105.09 116.52 21.26 20.71 21.20 6.67 3.78 4.65 4.51
21.83 21.63 20.69 20.03 21.29 22.45 14.38 14.21 13.96 0.01 -0.00 0.01 -0.00
CWIP -0.00 -0.00 0.35 0.40 0.53 0.43 0.43 0.43 0.43 -0.00 -0.00 -0.00 -0.00
Investments 0.03 0.03 0.07 0.08 0.08 0.07 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
45.41 43.68 40.42 53.15 83.19 93.57 6.45 6.07 6.81 6.66 3.78 4.64 4.51
Total Assets 67.27 65.34 61.53 73.66 105.09 116.52 21.26 20.71 21.20 6.67 3.78 4.65 4.51

(S): Standalone figures, shown where consolidated figures are not available.

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
-1.38 0.52 1.94 1.56 6.52 3.30 18.03 2.15 -0.25 -4.79 -0.41 -0.56
0.22 -0.86 -1.26 -0.90 -3.27 -3.09 0.07 -0.13 0.01 12.00 -0.00 0.04
1.73 0.27 -0.82 0.07 -2.89 -1.33 -9.86 -0.48 0.90 -3.49 0.33 0.75
Net Cash Flow 0.58 -0.07 -0.14 0.73 0.37 -1.12 8.25 1.55 0.66 3.72 -0.09 0.23
Free Cash Flow -1.38 -0.92 0.83 0.77 3.38 0.28 18.03 2.02 -0.24 7.21 -0.41 -0.52
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -14% 17% 47% 40% 104% 72% 1,454% 566% -47% 80% 46% 54%

(S): Standalone figures, shown where consolidated figures are not available.

Ratios

Consolidated / View Standalone

Mar 2015 (S) Mar 2016 (S) Mar 2017 (S) Mar 2018 (S) Mar 2019 (S) Mar 2020 (S) Mar 2021 (S) Mar 2022 (S) Mar 2023 (S) Mar 2024 (S) Mar 2025 (S) Mar 2026 (S)
Debtor Days 103.77 53.13 90.35 100.15 82.43 68.71 174.90 143.69 208.05 321.42 279.12 730.00
Inventory Days 192.30 148.72 158.21 152.21 100.07 117.80 169.10 136.29 279.94 4.92 34.76 -0.00
Days Payable 151.09 24.82 108.10 143.09 145.12 155.80 123.82 61.88 166.89 7.87 69.52
Cash Conversion Cycle 144.97 177.04 140.45 109.28 37.38 30.70 220.17 218.10 321.10 318.47 244.36 730.00
Working Capital Days 29.00 16.24 37.29 41.48 16.82 11.24 -87.22 -109.10 -43.19 357.74 1,524.41 2,993.00
ROCE % 12.07% 10.92% 9.57% 9.44% 11.77% 8.94% 3.24% 1.58% 1.80% -40.58% -25.11% -33.93%

(S): Standalone figures, shown where consolidated figures are not available.

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Number of operating manufacturing units
units ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of employees on rolls
employees ・Standalone data
Top product contribution to total turnover
% of turnover ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
7.36% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.24%
0.00% 0.00% 6.25% 6.25% 6.25% 6.53% 6.53% 1.68% 1.68% 1.68% 1.80% 0.67%
92.64% 98.76% 92.53% 92.52% 92.52% 92.24% 92.24% 97.08% 97.09% 97.10% 96.96% 98.09%
No. of Shareholders 12,31412,19211,95212,16512,09412,14412,03412,06011,83411,45211,38311,151

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents